Aurobindo Pharma Ltd.
BSE: 524804 | Sector: Health care |
NSE: AUROPHARMA | ISIN Code: INE406A01037 |
BSE 00:00 | 09 Apr | 943.65 |
36.60 (4.04%) |
OPEN
906.00 |
HIGH
952.80 |
LOW
905.00 |
NSE 00:00 | 09 Apr | 943.70 |
36.30 (4.00%) |
OPEN
902.00 |
HIGH
952.95 |
LOW
901.30 |
OPEN | 906.00 |
PREVIOUS CLOSE | 907.05 |
VOLUME | 125068 |
52-Week high | 1023.10 |
52-Week low | 393.75 |
P/E | 18.54 |
Mkt Cap.(Rs cr) | 55,288 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Aurobindo Pharma Ltd. (AUROPHARMA) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Sun Pharma.Inds. | 636.95 | 22.65 | 3.69 | 3211.14 |
Dr Reddy's Labs | 4759.50 | 69.30 | 1.48 | 2937.70 |
Cipla | 882.30 | 40.55 | 4.82 | 2318.17 |
Aurobindo Pharma | 943.65 | 36.60 | 4.04 | 1872.74 |
Cadila Health. | 514.55 | 43.85 | 9.32 | 1412.90 |
Divi's Lab. | 3751.15 | 35.20 | 0.95 | 1372.71 |
Glenmark Pharma. | 529.60 | 24.95 | 4.94 | 1354.55 |
Alkem Lab | 2832.25 | 126.00 | 4.66 | 1264.42 |
Alembic Pharma | 1010.65 | 39.50 | 4.07 | 969.40 |
Torrent Pharma. | 2573.40 | 24.40 | 0.96 | 938.51 |
Gland Pharma | 2530.00 | 17.30 | 0.69 | 772.86 |
Lupin | 1079.60 | 31.55 | 3.01 | 727.55 |
Ipca Labs. | 2085.10 | 21.40 | 1.04 | 652.46 |
Abbott India | 15245.80 | 198.30 | 1.32 | 592.93 |
Fortis Health. | 207.95 | -4.10 | -1.93 | 513.33 |
Pfizer | 4797.80 | 179.25 | 3.88 | 509.13 |
Sanofi India | 8227.25 | 85.05 | 1.04 | 477.60 |
Natco Pharma | 921.75 | 13.85 | 1.53 | 474.50 |
Apollo Hospitals | 3133.30 | 18.95 | 0.61 | 470.30 |
Granules India | 341.40 | 12.00 | 3.64 | 444.07 |
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices